-
COMPARATIVE EFFECTIVENESS OF SGLT2I, GLP-1, AND METFORMIN ON CARDIOVASCULAR OUTCOMES IN ADULTS WITH SEVERE MENTAL ILLNESS
Mar 18, 2026, 21:38 PM -
HEALTH AND ECONOMIC EFFECTS OF RECOMBINANT ZOSTER VACCINATION AMONG UNINSURED ADULTS IN THE UNITED STATES USING ALTERNATIVE VALUATION METHODS
Mar 18, 2026, 21:38 PM -
UNDERSTANDING THE GLOBAL ECONOMIC BURDEN OF HEPATITIS DELTA VIRUS: A SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR) CAPTURES A 2025 STANDARD-OF-CARE (SOC) SHIFT DRIVEN BY ANTIBODY-DRUG CONJUGATES (ADCS) IN UROTHELIAL CARCINOMA (UC): IMPLICATIONS FOR HEALTH TECHNOLOGY ASSESSMENTS (HTAS)
Mar 18, 2026, 21:38 PM -
USE OF REAL-TIME AI-ASSISTED LIVING SYSTEMATIC LITERATURE REVIEW (REAL-SLR) IN PROSTATE CANCER (PC) ENABLES ON-DEMAND ACCESS TO PIVOTAL CLINICAL TRIAL EVIDENCE
Mar 18, 2026, 21:38 PM -
SCOPING REVIEW OF REMOTE PATIENT MONITORING SOLUTIONS USING SENSOR-BASED TECHNOLOGIES IN ONCOLOGY CARE
Mar 18, 2026, 21:38 PM -
REAL-WORLD CONCORDANCE WITH THE FRAMINGHAM STROKE RISK MODEL IN ATRIAL FIBRILLATION AND IDENTIFICATION OF ADDITIONAL SIGNIFICANT FEATURES
Mar 18, 2026, 21:38 PM -
COST-BENEFIT ANALYSIS OF TUMOR TREATING FIELDS PLUS RADIOSURGERY FOR BRAIN METASTASES FROM NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN OF INCIDENT BRAIN METASTASES IN MEDICARE BENEFICIARIES WITH ALK+ METASTATIC NON-SMALL CELL LUNG CANCER
Mar 18, 2026, 21:38 PM -
DO MULTIPLE PRESENTATIONS AFFECT THE DURATION OF U.S. DRUG SHORTAGES?
Mar 18, 2026, 21:38 PM -
DEVELOPMENT OF A MULTI-AGENT "DEEP" AI SYSTEM FOR HEOR EVIDENCE AND INTELLIGENCE GENERATION
Mar 18, 2026, 21:38 PM -
FAMILY IMPACT OF ADULT ANGELMAN SYNDROME: CAREGIVER PERSPECTIVES
Mar 18, 2026, 21:38 PM -
COMBINING DISCRETE CHOICE EXPERIMENT AND CONTINGENT VALUATION TO ESTIMATE WILLINGNESS-TO-PAY FOR LYME DISEASE VACCINE ATTRIBUTES IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SEMAGLUTIDE FOR THE TREATMENT OF METABOLIC DYSFUNCTION-ASSOCIATED STEATOTIC LIVER DISEASE IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
FROM FINANCIAL STRAIN TO FINANCIAL CAPABILITY: OUTCOMES OF A FAMILY CAREGIVER TRAINING PROGRAM IN SEVERE MENTAL ILLNESS
Mar 18, 2026, 21:38 PM -
EFFECTIVENESS OF A CENTRALIZED COMMUNITY PHARMACY-BASED PATIENT ACCESS AND THERAPY MANAGEMENT PROGRAM FOR SPECIALTY-LITE MEDICATIONS: A NATIONAL REAL-WORLD STUDY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SUBCUTANEOUS MOSUNETUZUMAB PLUS POLATUZUMAB VEDOTIN VERSUS RITUXIMAB PLUS GEMCITABINE AND OXALIPLATIN FOR UNITED STATES (US) PATIENTS WITH AUTOLOGOUS STEM CELL TRANSPLANT-INELIGIBLE RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA
Mar 18, 2026, 21:38 PM -
SOCIAL DETERMINANTS OF HEALTH, MORTALITY, AND EXTENDED HOSPITAL STAY IN ATRIAL FIBRILLATION: LEVERAGING OPEN-SOURCE LARGE LANGUAGE MODELS
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF SEMAGLUTIDE 2.4 MG COMPARED WITH RESMETIROM AND STANDARD OF CARE FOR METABOLIC DYSFUNCTION-ASSOCIATED STEATOHEPATITIS (MASH) IN THE U.S. USING MOST FAVORED NATION (MFN) PRICING
Mar 18, 2026, 21:38 PM -
REAL-WORLD EFFECTIVENESS OF STATIN THERAPY AND PREDICTIVE MODELING OF ADHERENCE AMONG PATIENTS WITH SEVERE HYPERCHOLESTEROLEMIA
Mar 18, 2026, 21:38 PM
